VAERS Explorer
Back to explore

Report #2846892

Received Jun 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Jan 30, 2017
Onset
Jun 10, 2025
Days to onset
3053
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.4Y015599OT
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1—OT
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2—OT
HPV9HPV (GARDASIL 9)MERCK & CO. INC.3—OT

Symptoms (1)

Extra dose administered

Symptom narrative

patient reported no symptoms; Inadvertently administering a 4th dose of GARDASIL 9 to a 20 year old patient; This spontaneous report was received from a Nurse and refers to a(n) patient of unknown age and gender. The patient's medical history, concurrent conditions AND Concomitant therapies were not reported. On 30-Jan-2017, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), dose number 1, on 03-Apr-2017, dose number 2, and in August 2017, dose number 3, administered by Unknown route (lot # and expiration date were not reported). On 10-Jun-2025, the patient was inadvertently administered a fourth dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y015599, expiration date: 10-Feb-2027), administered by Unknown route (Extra dose administered). All doses administered for prophylaxis. The patient reported no symptoms or adverse events.